{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:53:51Z","timestamp":1793199231162,"version":"4.5.0"},"reference-count":64,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:00:00Z","timestamp":1616544000000},"content-version":"unspecified","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005693","name":"Parent Project Muscular Dystrophy","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005693","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2021,3,5]]},"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:p>Cardiac disease is now the leading cause of death in Duchenne muscular dystrophy (DMD). Clinical evaluations over time have demonstrated asymptomatic cardiac troponin elevations and acute elevations are associated with symptoms and cardiac dysfunction in DMD. Clinicians require a better understanding of the relationship of symptoms, troponin levels and progression of cardiac disease in DMD. As clinical trials begin to assess novel cardiac therapeutics in DMD, troponin levels in DMD are important for safety monitoring and outcome measures. The Parent Project Muscular Dystrophy convened an expert panel of cardiologists, scientists, and regulatory and industry specialists on 16 December 2019 in Silver Spring, Maryland and reviewed published and unpublished data from their institutions. The panel recommended retrospective troponin data analyses, prospective longitudinal troponin collection using high-sensitivity cardiac troponin I assays, inclusion of troponin in future clinical trial outcomes and future development of clinical guidelines for monitoring and treating troponin elevations in DMD.<\/jats:p>","DOI":"10.1136\/openhrt-2021-001592","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T12:43:18Z","timestamp":1616589798000},"page":"e001592","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":29,"title":["Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel"],"prefix":"10.1136","volume":"8","clinical-trial-number":[{"clinical-trial-number":"nct02921321","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02310763","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2493-5735","authenticated-orcid":false,"given":"Christopher F","family":"Spurney","sequence":"first","affiliation":[{"name":"Children's National Heart Institute, Children's National Hospital, Washington, District of Columbia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Ascheim","sequence":"additional","affiliation":[{"name":"D2A, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4133-7959","authenticated-orcid":false,"given":"Lawrence","family":"Charnas","sequence":"additional","affiliation":[{"name":"Clinical Research Rare Neurology Disease, Pfizer, Cambridge, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Cripe","sequence":"additional","affiliation":[{"name":"The Heart Center, Nationwide Children's Hospital, Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Hor","sequence":"additional","affiliation":[{"name":"The Heart Center, Nationwide Children's Hospital, Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"King","sequence":"additional","affiliation":[{"name":"Critical Path Institute, Tucson, Arizona, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathi","family":"Kinnett","sequence":"additional","affiliation":[{"name":"Parent Project Muscular Dystrophy, Hackensack, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M","family":"McNally","sequence":"additional","affiliation":[{"name":"Center for Genetic Medicine, Northwestern Medicine, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John-Michael","family":"Sauer","sequence":"additional","affiliation":[{"name":"Critical Path Institute, Tucson, Arizona, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Sweeney","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, University of Florida, Gainesville, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chet","family":"Villa","sequence":"additional","affiliation":[{"name":"Cardiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry W","family":"Markham","sequence":"additional","affiliation":[{"name":"Pediatrics, Division of Pediatric Cardiology, Riley Hospital for Children at Indiana University Health, Indianapolis, Indiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,3,24]]},"reference":[{"key":"2025081612202380000_8.1.e001592.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.08.1038"},{"key":"2025081612202380000_8.1.e001592.2","first-page":"723","article-title":"[The limitation of MB isoenzyme of creatine kinase mass in assess myocardial injury with muscular disease]","volume":"23","author":"Wang","year":"2011","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"2025081612202380000_8.1.e001592.3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11897-019-0420-5","article-title":"The role of troponin for acute heart failure","volume":"16","author":"Harrison","year":"2019","journal-title":"Curr Heart Fail Rep"},{"key":"2025081612202380000_8.1.e001592.4","first-page":"121","article-title":"Improvement of survival in Duchenne muscular dystrophy: retrospective analysis of 835 patients","volume":"31","author":"Passamano","year":"2012","journal-title":"Acta Myol"},{"key":"2025081612202380000_8.1.e001592.5","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0002-9149(64)90137-7","article-title":"Myocardial infarction in progressive muscular dystrophy","volume":"14","author":"Shapiro","year":"1964","journal-title":"Am J Cardiol"},{"key":"2025081612202380000_8.1.e001592.6","first-page":"784","article-title":"Myocardial infarction in a child aged ten with Duchenne muscular dystrophy","volume":"70","author":"Fiorista","year":"1981","journal-title":"Z Kardiol"},{"key":"2025081612202380000_8.1.e001592.7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JND-170253","article-title":"Progression of Duchenne cardiomyopathy presenting with chest pain and troponin elevation","volume":"4","author":"Hor","year":"2017","journal-title":"J Neuromuscul Dis"},{"key":"2025081612202380000_8.1.e001592.8","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00246-020-02372-5","article-title":"Troponin I levels correlate with cardiac Mr LGE and native T1 values in Duchenne muscular dystrophy cardiomyopathy and identify early disease progression","volume":"41","author":"Voleti","year":"2020","journal-title":"Pediatr Cardiol"},{"key":"2025081612202380000_8.1.e001592.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.03.027"},{"key":"2025081612202380000_8.1.e001592.10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.115.001322"},{"key":"2025081612202380000_8.1.e001592.11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1515\/dx-2019-0045","article-title":"Skeletal myopathies as a non-cardiac cause of elevations of cardiac troponin concentrations","volume":"6","author":"Giannitsis","year":"2019","journal-title":"Diagnosis"},{"key":"2025081612202380000_8.1.e001592.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.08.026"},{"key":"2025081612202380000_8.1.e001592.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.01.070"},{"key":"2025081612202380000_8.1.e001592.14","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/clinchem\/41.12.1710","article-title":"Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue","volume":"41","author":"Bodor","year":"1995","journal-title":"Clin Chem"},{"key":"2025081612202380000_8.1.e001592.15","article-title":"Evaluating the diagnostic and prognostic value of biomarkers for heart disease and major adverse cardiac events in patients with muscular dystrophy","author":"Nikhanj","year":"2020","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2025081612202380000_8.1.e001592.16","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.19082\/5732","article-title":"Evaluation of cardiac functions in children with Duchenne muscular dystrophy: a prospective case-control study","volume":"9","author":"Sadek","year":"2017","journal-title":"Electron Physician"},{"key":"2025081612202380000_8.1.e001592.17","first-page":"984","article-title":"[Comparison analysis of muscle enzymes in children with myocarditis and Duchene\/Becker muscular dystrophy]","volume":"41","author":"Zhang","year":"2016","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"2025081612202380000_8.1.e001592.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2007.01.009"},{"key":"2025081612202380000_8.1.e001592.19","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/clinchem\/47.3.451","article-title":"Clinical and experimental results on cardiac troponin expression in Duchenne muscular dystrophy","volume":"47","author":"Hammerer-Lercher","year":"2001","journal-title":"Clin Chem"},{"key":"2025081612202380000_8.1.e001592.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2011.02.016"},{"key":"2025081612202380000_8.1.e001592.21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.braindev.2008.09.006","article-title":"Cardiac troponin I for accurate evaluation of cardiac status in myopathic patients","volume":"31","author":"Castro-Gago","year":"2009","journal-title":"Brain Dev"},{"key":"2025081612202380000_8.1.e001592.22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/AC.67.2.2154220","article-title":"Elevated troponin T levels in a female carrier of Duchenne muscular dystrophy with normal coronary angiogram: a case report and review of the literature","volume":"67","author":"De Pooter","year":"2012","journal-title":"Acta Cardiol"},{"key":"2025081612202380000_8.1.e001592.23","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318221ad14"},{"key":"2025081612202380000_8.1.e001592.24","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/clinchem\/47.5.962","article-title":"Troponin T and troponin I in carriers of Duchenne and Becker muscular dystrophy with cardiac involvement","volume":"47","author":"Hoogerwaard","year":"2001","journal-title":"Clin Chem"},{"key":"2025081612202380000_8.1.e001592.25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174166","article-title":"Elevated plasma levels of cardiac troponin-I predict left ventricular systolic dysfunction in patients with myotonic dystrophy type 1: a multicentre cohort follow-up study","volume":"12","author":"Hamilton","year":"2017","journal-title":"PLoS One"},{"key":"2025081612202380000_8.1.e001592.26","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.ijcard.2012.04.159","article-title":"Elevation of serum cardiac troponin I in a cross-sectional cohort of asymptomatic subjects with Friedreich ataxia","volume":"167","author":"Friedman","year":"2013","journal-title":"Int J Cardiol"},{"key":"2025081612202380000_8.1.e001592.27","unstructured":"Zolgensma prescribing information. Available: https:\/\/www.avexis.com\/us\/Content\/pdf\/ prescribing_information.pdf [Accessed 20 Jul 2020]."},{"key":"2025081612202380000_8.1.e001592.28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/clinchem\/47.3.451","article-title":"Clinical and experimental results on cardiac troponin expression in Duchenne muscular dystrophy","volume":"47","author":"Hammerer-Lercher","year":"2001","journal-title":"Clin Chem"},{"key":"2025081612202380000_8.1.e001592.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2013.12.008"},{"key":"2025081612202380000_8.1.e001592.30","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn406"},{"key":"2025081612202380000_8.1.e001592.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2017.06.004"},{"key":"2025081612202380000_8.1.e001592.32","doi-asserted-by":"publisher","DOI":"10.1172\/JCI41329"},{"key":"2025081612202380000_8.1.e001592.33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.nmd.2016.02.005","article-title":"Suspected acute myocardial infarction in a dystrophin-deficient dog","volume":"26","author":"Schneider","year":"2016","journal-title":"Neuromuscul Disord"},{"key":"2025081612202380000_8.1.e001592.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2009.01.014"},{"key":"2025081612202380000_8.1.e001592.35","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cca.2016.04.029","article-title":"Plasma cardiac troponin I concentrations in healthy neonates, children and adolescents measured with a high sensitive immunoassay method: high sensitive troponin I in pediatric age","volume":"458","author":"Caselli","year":"2016","journal-title":"Clin Chim Acta"},{"key":"2025081612202380000_8.1.e001592.36","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2012.192054"},{"key":"2025081612202380000_8.1.e001592.37","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jamacardio.2018.2695","article-title":"Myocarditis in Duchenne muscular dystrophy after changing steroids","volume":"3","author":"Abutaleb","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2025081612202380000_8.1.e001592.38","first-page":"180","article-title":"Acute myocardial injury in a child with Duchenne muscular dystrophy: pulse steroid therapy?","volume":"12","author":"Cinteza","year":"2017","journal-title":"Maedica"},{"key":"2025081612202380000_8.1.e001592.39","first-page":"817","article-title":"[Acute myocardial infarction in a 13-year-old boy with Duchenne's disease]","volume":"14","author":"Cuccia","year":"1984","journal-title":"G Ital Cardiol"},{"key":"2025081612202380000_8.1.e001592.40","first-page":"5","article-title":"St-Segment displacement in Duchenne muscular dystrophy: myocardial necrosis or apoptosis?","volume":"22","author":"Politano","year":"2003","journal-title":"Acta Myol"},{"key":"2025081612202380000_8.1.e001592.41","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.annfar.2008.01.006","article-title":"El\u00e9vation de troponine I coronarographie normale chez un patient porteur d'une myopathie de Duchenne [Increased troponin I level in a Duchenne muscular dystrophy patient with normal coronarography]","volume":"27","author":"Schoeffler","year":"2008","journal-title":"Ann Fr Anesth Reanim"},{"key":"2025081612202380000_8.1.e001592.42","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000526"},{"key":"2025081612202380000_8.1.e001592.43","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.015151"},{"key":"2025081612202380000_8.1.e001592.44","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70271-6"},{"key":"2025081612202380000_8.1.e001592.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2004.05.006"},{"key":"2025081612202380000_8.1.e001592.46","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-2448"},{"key":"2025081612202380000_8.1.e001592.47","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clinbiochem.2015.01.004","article-title":"Use and interpretation of high sensitivity cardiac troponins in patients with chronic kidney disease with and without acute myocardial infarction","volume":"48","author":"Parikh","year":"2015","journal-title":"Clin Biochem"},{"key":"2025081612202380000_8.1.e001592.48","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21420"},{"key":"2025081612202380000_8.1.e001592.49","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1161\/CIRCULATIONAHA.118.038772","article-title":"High-sensitivity troponin I and incident coronary events, stroke, heart failure hospitalization, and mortality in the ARIC study","volume":"139","author":"Jia","year":"2019","journal-title":"Circulation"},{"key":"2025081612202380000_8.1.e001592.50","doi-asserted-by":"crossref","first-page":"139","DOI":"10.23736\/S0026-4806.18.05874-3","article-title":"Clinical use of cardiac troponin for acute cardiac care and emerging opportunities in the outpatient setting","volume":"110","author":"Sandoval","year":"2019","journal-title":"Minerva Med"},{"key":"2025081612202380000_8.1.e001592.51","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70318-7"},{"key":"2025081612202380000_8.1.e001592.52","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0590-8"},{"key":"2025081612202380000_8.1.e001592.53","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013501","article-title":"Stabilization of early Duchenne cardiomyopathy with aldosterone inhibition: results of the multicenter AIDMD trial","volume":"8","author":"Raman","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2025081612202380000_8.1.e001592.54","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1002\/ehf2.12996","article-title":"Mineralocorticoid receptor antagonism by finerenone is sufficient to improve function in preclinical muscular dystrophy","volume":"7","author":"Lowe","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2025081612202380000_8.1.e001592.55","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00269.2016"},{"key":"2025081612202380000_8.1.e001592.56","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2019.01324","article-title":"Mineralocorticoid receptor signaling contributes to normal muscle repair after acute injury","volume":"10","author":"Hauck","year":"2019","journal-title":"Front Physiol"},{"key":"2025081612202380000_8.1.e001592.57","doi-asserted-by":"crossref","first-page":"e1312","DOI":"10.1212\/WNL.0000000000008168","article-title":"Cooperative international neuromuscular Research Group. Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function","volume":"93","author":"Hoffman","year":"2019","journal-title":"Neurology"},{"key":"2025081612202380000_8.1.e001592.58","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.201800186"},{"key":"2025081612202380000_8.1.e001592.59","doi-asserted-by":"crossref","first-page":"e866","DOI":"10.1212\/WNL.0000000000006950","article-title":"Cardiac and skeletal muscle effects in the randomized HOPE-Duchenne trial","volume":"92","author":"Taylor","year":"2019","journal-title":"Neurology"},{"key":"2025081612202380000_8.1.e001592.60","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.nmd.2020.05.002","article-title":"Randomized phase 2 trial and open-label extension of domagrozumab in Duchenne muscular dystrophy","volume":"30","author":"Wagner","year":"2020","journal-title":"Neuromuscul Disord"},{"key":"2025081612202380000_8.1.e001592.61","unstructured":"Parent Project Muscular Dystrophy Webinar . Domagrozumab (anti-myostatin) as a potential treatment for Duchenne muscular dystrophy, 2019. Available: https:\/\/www.bing.com\/videos\/search?q=PPMD+webinar+youtube+domagrozumab&docid=607991159651436986&mid=69262C4747B046776CE669262C4747B046776CE6&view=detail&FORM=VIRE [Accessed 13 Oct 2020]."},{"key":"2025081612202380000_8.1.e001592.62","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1007\/s00246-017-1703-9","article-title":"Interleukin 1 receptor-like 1 protein (ST2) is a potential biomarker for cardiomyopathy in Duchenne muscular dystrophy","volume":"38","author":"Anderson","year":"2017","journal-title":"Pediatr Cardiol"},{"key":"2025081612202380000_8.1.e001592.63","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cardfail.2019.02.006","article-title":"The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in Duchenne muscular dystrophy cardiomyopathy","volume":"25","author":"Soslow","year":"2019","journal-title":"J Card Fail"},{"key":"2025081612202380000_8.1.e001592.64","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.2217\/bmm-2018-0125","article-title":"Cardiac MRI biomarkers for Duchenne muscular dystrophy","volume":"12","author":"Magrath","year":"2018","journal-title":"Biomark Med"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2021-001592","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T19:20:37Z","timestamp":1755372037000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2021-001592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,3,24]]},"published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1136\/openhrt-2021-001592"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2021-001592","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}